Relationship between glycosylated hemoglobin and blood glucose during progression of chronic kidney disease

Rajiv Agarwal, Robert P. Light

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: The value of measurement of glycosylated hemoglobin (HgbA 1C) in determining the degree of glycemic control in patients with chronic kidney disease (CKD) is unclear. Methods: A single-center, prospective cohort study was conducted in 128 veterans with diabetes mellitus and CKD. HgbA 1C was measured as clinically indicated and its relationship with random blood glucose (RBG) measurement evaluated prospectively over up to 10 years in three groups (end-stage renal disease (ESRD), CKD and controls who had diabetes but no CKD). Results: Between 1995 and 2011, in the control group, glycemic control as assessed by HgbA 1C was stable but improved when assessed by RBG. However, both the CKD and ESRD groups experienced declines in RBG and HgbA 1C. Declining HgbA 1C and RBG were noted prior to onset of dialysis. A fall in HgbA 1C remained after adjustment for RBG. A strong inverse relationship was seen between CKD stage and HgbA 1C even after adjusting for RBG such that the relationship between RBG levels and HgbA 1C was modified by CKD. Conclusions: In diabetic patients with late-stage CKD, glycemic control shows an improvement. However, HgbA 1C <7% may overestimate the degree of glycemic control. Therefore, reliance on HgbA 1C without home blood glucose monitoring may result in poor diabetes control.

Original languageEnglish
Pages (from-to)32-41
Number of pages10
JournalAmerican Journal of Nephrology
Volume34
Issue number1
DOIs
StatePublished - Jul 2011

Fingerprint

Glycosylated Hemoglobin A
Chronic Renal Insufficiency
Blood Glucose
Chronic Kidney Failure
Blood Glucose Self-Monitoring
Veterans
Dialysis
Diabetes Mellitus
Cohort Studies
Prospective Studies
Control Groups

Keywords

  • Chronic kidney disease
  • Cohort studies
  • Diabetes mellitus
  • End-stage renal disease
  • Glycemic control

ASJC Scopus subject areas

  • Nephrology

Cite this

Relationship between glycosylated hemoglobin and blood glucose during progression of chronic kidney disease. / Agarwal, Rajiv; Light, Robert P.

In: American Journal of Nephrology, Vol. 34, No. 1, 07.2011, p. 32-41.

Research output: Contribution to journalArticle

@article{9f66ca74142b4b04a4274b47b93f24ca,
title = "Relationship between glycosylated hemoglobin and blood glucose during progression of chronic kidney disease",
abstract = "Background: The value of measurement of glycosylated hemoglobin (HgbA 1C) in determining the degree of glycemic control in patients with chronic kidney disease (CKD) is unclear. Methods: A single-center, prospective cohort study was conducted in 128 veterans with diabetes mellitus and CKD. HgbA 1C was measured as clinically indicated and its relationship with random blood glucose (RBG) measurement evaluated prospectively over up to 10 years in three groups (end-stage renal disease (ESRD), CKD and controls who had diabetes but no CKD). Results: Between 1995 and 2011, in the control group, glycemic control as assessed by HgbA 1C was stable but improved when assessed by RBG. However, both the CKD and ESRD groups experienced declines in RBG and HgbA 1C. Declining HgbA 1C and RBG were noted prior to onset of dialysis. A fall in HgbA 1C remained after adjustment for RBG. A strong inverse relationship was seen between CKD stage and HgbA 1C even after adjusting for RBG such that the relationship between RBG levels and HgbA 1C was modified by CKD. Conclusions: In diabetic patients with late-stage CKD, glycemic control shows an improvement. However, HgbA 1C <7{\%} may overestimate the degree of glycemic control. Therefore, reliance on HgbA 1C without home blood glucose monitoring may result in poor diabetes control.",
keywords = "Chronic kidney disease, Cohort studies, Diabetes mellitus, End-stage renal disease, Glycemic control",
author = "Rajiv Agarwal and Light, {Robert P.}",
year = "2011",
month = "7",
doi = "10.1159/000328737",
language = "English",
volume = "34",
pages = "32--41",
journal = "American Journal of Nephrology",
issn = "0250-8095",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Relationship between glycosylated hemoglobin and blood glucose during progression of chronic kidney disease

AU - Agarwal, Rajiv

AU - Light, Robert P.

PY - 2011/7

Y1 - 2011/7

N2 - Background: The value of measurement of glycosylated hemoglobin (HgbA 1C) in determining the degree of glycemic control in patients with chronic kidney disease (CKD) is unclear. Methods: A single-center, prospective cohort study was conducted in 128 veterans with diabetes mellitus and CKD. HgbA 1C was measured as clinically indicated and its relationship with random blood glucose (RBG) measurement evaluated prospectively over up to 10 years in three groups (end-stage renal disease (ESRD), CKD and controls who had diabetes but no CKD). Results: Between 1995 and 2011, in the control group, glycemic control as assessed by HgbA 1C was stable but improved when assessed by RBG. However, both the CKD and ESRD groups experienced declines in RBG and HgbA 1C. Declining HgbA 1C and RBG were noted prior to onset of dialysis. A fall in HgbA 1C remained after adjustment for RBG. A strong inverse relationship was seen between CKD stage and HgbA 1C even after adjusting for RBG such that the relationship between RBG levels and HgbA 1C was modified by CKD. Conclusions: In diabetic patients with late-stage CKD, glycemic control shows an improvement. However, HgbA 1C <7% may overestimate the degree of glycemic control. Therefore, reliance on HgbA 1C without home blood glucose monitoring may result in poor diabetes control.

AB - Background: The value of measurement of glycosylated hemoglobin (HgbA 1C) in determining the degree of glycemic control in patients with chronic kidney disease (CKD) is unclear. Methods: A single-center, prospective cohort study was conducted in 128 veterans with diabetes mellitus and CKD. HgbA 1C was measured as clinically indicated and its relationship with random blood glucose (RBG) measurement evaluated prospectively over up to 10 years in three groups (end-stage renal disease (ESRD), CKD and controls who had diabetes but no CKD). Results: Between 1995 and 2011, in the control group, glycemic control as assessed by HgbA 1C was stable but improved when assessed by RBG. However, both the CKD and ESRD groups experienced declines in RBG and HgbA 1C. Declining HgbA 1C and RBG were noted prior to onset of dialysis. A fall in HgbA 1C remained after adjustment for RBG. A strong inverse relationship was seen between CKD stage and HgbA 1C even after adjusting for RBG such that the relationship between RBG levels and HgbA 1C was modified by CKD. Conclusions: In diabetic patients with late-stage CKD, glycemic control shows an improvement. However, HgbA 1C <7% may overestimate the degree of glycemic control. Therefore, reliance on HgbA 1C without home blood glucose monitoring may result in poor diabetes control.

KW - Chronic kidney disease

KW - Cohort studies

KW - Diabetes mellitus

KW - End-stage renal disease

KW - Glycemic control

UR - http://www.scopus.com/inward/record.url?scp=79958073061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958073061&partnerID=8YFLogxK

U2 - 10.1159/000328737

DO - 10.1159/000328737

M3 - Article

C2 - 21659737

AN - SCOPUS:79958073061

VL - 34

SP - 32

EP - 41

JO - American Journal of Nephrology

JF - American Journal of Nephrology

SN - 0250-8095

IS - 1

ER -